Scientific and ethical issues related to stem cell research and interventions in neurodegenerative disorders of the brain

@article{Barker2013ScientificAE,
  title={Scientific and ethical issues related to stem cell research and interventions in neurodegenerative disorders of the brain},
  author={Roger A. Barker and Inez de Beaufort},
  journal={Progress in Neurobiology},
  year={2013},
  volume={110},
  pages={63-73}
}
Should patients with Parkinson's disease participate in research involving stem cell treatments? Are induced pluripotent stem cells (iPSC) the ethical solution to the moral issues regarding embryonic stem cells? How can we adapt trial designs to best assess small numbers of patients in receipt of invasive experimental therapies? Over the last 20 years there has been a revolution in our ability to make stem cells from different sources and use them for therapeutic gain in disorders of the brain… Expand
Ethical Challenges of Stem-Cell Transplantation in Parkinson's Disease: Islamic Viewpoint
We read with great interest the article entitled “Ethical Criteria for Human Trials of Stem-Cell-Derived Dopaminergic Neurons in Parkinson’s Disease” by Hurst and colleagues (2015). Hurst andExpand
Cell therapies for Parkinson's disease: how far have we come?
TLDR
There is now much interest in how dopaminergic neurons derived from stem cell sources could be used to develop cell-based therapies suitable for clinical use, with clinical trials poised to enter the clinic in the next couple of years. Expand
Are Stem Cell-Based Therapies for Parkinson’s Disease Ready for the Clinic in 2016?
TLDR
The current state-of-art regarding human stem cell-derived dopamine neurons for use in any patient trial is described and the time is ripe for clinical translation of parthenogenetic stem cell technology in Parkinson’s disease is critically assessed. Expand
First-in-human cell transplant trials in Parkinson's disease: The need for an improved informed consent process.
TLDR
The ethical issues that researchers conducting first-in-human clinical trials of innovative medical procedures will face when trying to obtain a genuinely informed consent are called into question, and possible solutions are suggested. Expand
The therapeutic potential of exogenous adult stem cells for the injured central nervous system
TLDR
Clinical translation has thus far been impeded by only modest efficacy outcomes in clinical trials, speaking to a need for greater consistency and controls in such studies. Expand
Could Stem Cells Be Used to Treat or Model Alzheimer’s Disease?
TLDR
The mechanisms that underlie the effects of stem cell transplantation and the considerable challenge in translating these findings toward clinical trials are examined and the potential clinical and disease-modeling applications of patient-derived iPSCs for AD are discussed. Expand
Stem Cell-Based Therapies for Polyglutamine Diseases.
TLDR
In this chapter the main advantages and disadvantages of the available sources of stem cells as well as their efficacy and potential to improve disease outcomes are discussed. Expand
Recent advances in stem cells therapy: A focus on cancer, Parkinson’s and Alzheimer’s
TLDR
The clinical trials executed using stem cell therapy in an attempt to cure challenging diseases like cancer, Parkinson's and Alzheimer’s diseases are reviewed. Expand
Organoid and pluripotent stem cells in Parkinson’s disease modeling: an expert view on their value to drug discovery
TLDR
The use of Parkinson’s disease patient-derived neurons and organoids provides the exciting opportunity to directly investigate pathogenic mechanisms and test drug compounds in human neurons. Expand
An overview on ethical considerations in stem cell research in Iran and ethical recommendations: A review
  • T. Farajkhoda
  • Medicine
  • International journal of reproductive biomedicine
  • 2017
TLDR
There is a necessity for extending global networks of bioethics for strengthening communications within organizations at both the regional and international level, strengthening legislation systems, designing and establishing convenient collaborative educational courses at different levels. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 119 REFERENCES
Stem-cell therapy for amyotrophic lateral sclerosis
CONTEXT With the lack of effective drug treatments for amyotrophic lateral sclerosis (ALS), and compelling preclinical data, stem-cell research has highlighted this disease as a candidate forExpand
Embryo Stem Cell Research: Ten Years of Controversy
  • J. Robertson
  • Political Science, Medicine
  • Journal of Law, Medicine & Ethics
  • 2010
TLDR
The main issues that have bedeviled stem cell progress are assessed and the ethical fault lines that are likely to continue are identified and the field is poised for a period of rapid development. Expand
Uncertain Translation, Uncertain Benefit and Uncertain Risk: Ethical Challenges Facing First‐In‐Human Trials of Induced Pluripotent Stem (IPS) Cells
TLDR
It is concluded that iPS cell research should not replace, but proceed alongside embryonic and adult somatic stem cell research to promote cross-fertilisation of knowledge and better clinical outcomes. Expand
Stem cell treatment in Amyotrophic Lateral Sclerosis
TLDR
The results seem to demonstrate that MSCs represent a good chance for stem cell cell-based therapy in ALS and that intraspinal injection of M SCs is safe also in the long term. Expand
Stem cell therapy in amyotrophic lateral sclerosis: a methodological approach in humans
  • L. Mazzini, F. Fagioli, +6 authors E. Madon
  • Medicine
  • Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases
  • 2003
TLDR
The results appear to demonstrate that the procedures of ex vivo expansion of autologous mesenchymal stem cells and of transplantation into the spinal cord of humans are safe and well tolerated by ALS patients. Expand
Dopaminergic transplantation for parkinson's disease: Current status and future prospects
TLDR
Findings do not bode well for the short‐term future of cell‐based dopaminergic therapies in PD, as implanted dopamine neurons have been found to contain Lewy bodies, suggesting that they are dysfunctional and may have been affected by the PD pathological process. Expand
Sham neurosurgical procedures in clinical trials for neurodegenerative diseases: scientific and ethical considerations
TLDR
A framework of points for investigators to consider when designing trials that involve direct delivery of a therapeutic agent to the CNS, and the need to minimise bias and confounds is developed. Expand
Immunogenicity of induced pluripotent stem cells.
TLDR
A new study shows the immunogenicity of induced pluripotent stem cells by the direct transplantation of undifferentiated cells into syngenic mice, indicating that cells differentiated from iPSCs can at least partially replace the biological functions of various organs. Expand
Translational stem cell therapy for amyotrophic lateral sclerosis
TLDR
Key research that supports the use of stem cells as a therapy for ALS is highlighted, and the rationale behind and approach to the phase I trial of direct intraspinal transplantation of neural stem cells is discussed. Expand
Parkinson's disease and growth factors - are they the answer?
  • R. Barker
  • Medicine
  • Parkinsonism & related disorders
  • 2009
TLDR
Some patients have shown a sustained clinical response to this treatment which correlates with evidence of increased dopaminergic activity in the brain at the site of delivery using F-dopa PET as well as in a single post-mortem study. Expand
...
1
2
3
4
5
...